1Janice M. Walshe,Arlene W. Berman,Ujala Vatas,Seth M. Steinberg,William F. Anderson,Marc E. Lippman,Sandra M. Swain. A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up[J] 2007,Breast Cancer Research and Treatment(2):177～183
2Daniel Albo,Frederick C. Ames,Kelly K. Hunt,Merrick I. Ross,S. Eva Singletary,Henry M. Kuerer. Evaluation of Lymph Node Status in Male Breast Cancer Patients: A Role for Sentinel Lymph Node Biopsy*[J] 2003,Breast Cancer Research and Treatment(1):9～14
6JEMAL A, MURRAY T, SAMUELS A, et al. Cancer statistics, 2003[J]. CA Cancer J Clin, 2003, 53: 5-26.
7JOHANNSSON O, LOMAN N, MOLLER T, et al. Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriel-[J]. Enr J Cancer, 1999, 35(8): 1248-1257.
8HODGSON NC, BUTTON JH, FRANCESCHI D, et al. Male breast cancel: is the incidence increasing[J]. Ann Surg Oncol, 2004, 11(8): 751-755.
9CRICHLOW RW. Carcinoma of the male breat[J]. Surg Gynecol Obstet, 1972, 134: 1011-1019.
10SCOTT-CONNER CE, JOCHIMSEN PR, MENCK RH, et M. An analysis of male and female breast cancer treatment and survival among demogyaphically identical pairs of patients [J]. Srugery 1999, 126: 775-780, discussion 780-781.
